That approach helps reduce GI side effects
Clinically, you begin your treatment at the low 0.25mg volume for the first 4 weeks to allow your body to adapt. In the 5th week, under medical guidance, you step up your dosage to 0.5mg using the same system to optimize fat reduction progress
Il farmaco agisce come agonista del recettore GLP-1 (glucagon-like peptide-1), mimando lazione di questo incretino endogeno
Within the SELECT population with BMI 30 kg m 2 or 27 kg m 2 with at least one obesity-related comorbidity, the mean weight loss was 14.9% at week 68, compared with 2.4% with placebo 14
If you are experiencing any of the bloating, gas, changes in bowel habits, sudden urges to go to the toilet, uncontrolled weight loss or fatigue always seek advice from a trusted healthcare professional